Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease

BACKGROUND: Weight loss is recommended as the primary treatment for nonalcoholic fatty liver disease (NAFLD). However, the magnitude and velocity of hepatic steatosis resolution with weight loss is unclear, making it difficult to counsel patients seeking weight loss for treatment of NAFLD. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Behari, Jaideep, Graham, Lisa, Wang, Renwei, Schirda, Claudiu, Borhani, Amir A., Methé, Barbara A., Li, Kelvin, Morris, Alison, Luu, Hung N., Palmieri, Sabrina, Yuan, Jian‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019274/
https://www.ncbi.nlm.nih.gov/pubmed/33841891
http://dx.doi.org/10.1002/osp4.476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019274/
https://www.ncbi.nlm.nih.gov/pubmed/33841891
http://dx.doi.org/10.1002/osp4.476

Ejemplares similares